U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H28N4O6.ClH
Molecular Weight 504.963
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LAMIFIBAN HYDROCHLORIDE

SMILES

Cl.NC(=N)C1=CC=C(C=C1)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N3CCC(CC3)OCC(O)=O

InChI

InChIKey=YUWYXULCUNUQCG-BDQAORGHSA-N
InChI=1S/C24H28N4O6.ClH/c25-22(26)16-3-5-17(6-4-16)23(32)27-20(13-15-1-7-18(29)8-2-15)24(33)28-11-9-19(10-12-28)34-14-21(30)31;/h1-8,19-20,29H,9-14H2,(H3,25,26)(H,27,32)(H,30,31);1H/t20-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C24H28N4O6
Molecular Weight 468.5023
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

LAMIFIBAN is a potent and selective nonpeptide glycoprotein IIb/IIIa antagonist. It inhibits platelet aggregation and thrombus formation by preventing the binding of fibrinogen to platelets. It was in clinical development as an injectable antithrombotic agent for treating and preventing acute coronary syndromes but showed no significant effects on clinical outcomes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
1.4 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes.
2002-01-22
Lamifiban.
1999-05
Lamifiban.
1999-02
Orally active fibrinogen receptor antagonists. 2. Amidoximes as prodrugs of amidines.
1996-08-02
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:17:55 GMT 2025
Edited
by admin
on Mon Mar 31 18:17:55 GMT 2025
Record UNII
3UZ1CTQ989
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LAMIFIBAN HYDROCHLORIDE
USAN  
USAN  
Official Name English
RO 44-9883/023
Preferred Name English
(S)-((1-(2-((4-(AMINOIMINOMETHYL)BENZOYL)AMINO)-3-(4-HYDROXYPHENYL)-1-OXOPROPYL)-4-PIPERIDINYL)OXY)ACETIC ACID MONOHYDROCHLORIDE
Systematic Name English
((1-(N-(P-AMIDINOBENZOYL)-L-TYROSYL)-4-PIPERIDYL)OXY)ACETIC ACID MONOHYDROCHLORIDE
Common Name English
LAMIFIBAN HCL
Common Name English
LAMIFIBAN HYDROCHLORIDE [USAN]
Common Name English
RO-44-9883/023
Code English
Classification Tree Code System Code
NCI_THESAURUS C1327
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID80947247
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
USAN
MM-37
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
ChEMBL
CHEMBL108111
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
NCI_THESAURUS
C81568
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
FDA UNII
3UZ1CTQ989
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
PUBCHEM
3038483
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
CAS
243835-65-6
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
SMS_ID
300000055185
Created by admin on Mon Mar 31 18:17:55 GMT 2025 , Edited by admin on Mon Mar 31 18:17:55 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY